Captopril Tablet
NDC 11788-135
Product Information
Captopril is a ANDA-approved product labeled by Aiping Pharmaceutical, Inc.. Captopril is used to treat high blood pressure (hypertension). It is supplied as a white tablet for oral administration. This product entry covers the primary NDC 11788-135 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
C;125
Code Structure Chart
Product Details
What is NDC 11788-135?
What are the uses of this product?
What are Active Ingredients of this product?
- CAPTOPRIL 12.5 mg/1 - A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CAPTOPRIL (UNII: 9G64RSX1XD)
- CAPTOPRIL (UNII: 9G64RSX1XD) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ANHYDROUS LACTOSE (UNII: 3SY5LH9PMK)
- MICROCRYSTALLINE CELLULOSE 102 (UNII: PNR0YF693Y)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- CROSPOVIDONE (UNII: 2S7830E561)
- STEARIC ACID (UNII: 4ELV7Z65AP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 308962 - captopril 100 MG Oral Tablet
- RxCUI: 308963 - captopril 12.5 MG Oral Tablet
- RxCUI: 308964 - captopril 50 MG Oral Tablet
- RxCUI: 317173 - captopril 25 MG Oral Tablet
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.